Singapore markets close in 7 hours 42 minutes
  • Straits Times Index

    3,128.03
    -6.84 (-0.22%)
     
  • Nikkei

    26,654.57
    -150.03 (-0.56%)
     
  • Hang Seng

    21,996.89
    0.00 (0.00%)
     
  • FTSE 100

    7,312.32
    -11.09 (-0.15%)
     
  • BTC-USD

    20,056.04
    -249.15 (-1.23%)
     
  • CMC Crypto 200

    431.34
    -8.33 (-1.89%)
     
  • S&P 500

    3,818.83
    -2.72 (-0.07%)
     
  • Dow

    31,029.31
    +82.32 (+0.27%)
     
  • Nasdaq

    11,177.89
    -3.65 (-0.03%)
     
  • Gold

    1,820.10
    +2.60 (+0.14%)
     
  • Crude Oil

    109.36
    -0.42 (-0.38%)
     
  • 10-Yr Bond

    3.0930
    -0.1130 (-3.52%)
     
  • FTSE Bursa Malaysia

    1,455.58
    +4.10 (+0.28%)
     
  • Jakarta Composite Index

    6,942.35
    -54.10 (-0.77%)
     
  • PSE Index

    6,303.19
    -42.22 (-0.67%)
     

Is This Dividend Growth Stock a Buy?

·3-min read
Is This Dividend Growth Stock a Buy?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The pharma stock Eli Lilly (NYSE: LLY) has surged 13% higher year to date. Let's dive into Eli Lilly's fundamentals and valuation to find out. Eli Lilly reported $7.8 billion in revenue for the first quarter ended March 31, up 14.8% from the year-ago period.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting